Abstract
Studies of carbohydrate metabolism were conducted before and after 18 months of daily use of a 0.075-mg norgestrel preparation by 50 "normal" women. Each study involved a 3-hour oral glucose tolerance test. There was a significant increase in the weights of the women over the time of study. In addition, all of the plasma insulin values and all of the blood glucose values were significantly elevated at the 18-month test. All of the control glucose tolerance tests were normal initially, but eight (16%) of the glucose curves were abnormal at the 18-month test. These data suggest a systemic metabolic effect of norgestrel which may play a role in accelerating atherogenesis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
